Why Is Omeros Stock Trading Lower Tuesday?
Omeros Corp. (NASDAQ:OMER) stock fell sharply Tuesday after the biotechnology company reported mixed third-quarter 2026 results, with adjusted earnings exceeding Wall Street expectations but revenue falling short . The company reported adjusted earnings of 6 cents per share, beating the consensus estimate of 3 cents . Revenue reached $35.93 million, missing the consensus estimate of $37.27…
We haven't written up this one. Benzinga has the full story — the link below goes straight to it.